These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 8538031
21. Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. Mulligan LM, Marsh DJ, Robinson BG, Schuffenecker I, Zedenius J, Lips CJ, Gagel RF, Takai SI, Noll WW, Fink M. J Intern Med; 1995 Oct; 238(4):343-6. PubMed ID: 7595170 [Abstract] [Full Text] [Related]
22. RET oncogene mutations in medullary thyroid carcinoma in Mexican families. González B, Salcedo M, Medrano ME, Mantilla A, Quiñónez G, Benítez-Bribiesca L, Rodríguez-Cuevas S, Cabrera L, de León B, Altamirano N, Tapia J, Dawson B. Arch Med Res; 2003 Oct; 34(1):41-9. PubMed ID: 12604374 [Abstract] [Full Text] [Related]
23. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. Learoyd DL, Marsh DJ, Richardson AL, Twigg SM, Delbridge L, Robinson BG. Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617 [Abstract] [Full Text] [Related]
24. Multiple endocrine neoplasia, the old and the new: a mini review. Pasquali D, Di Matteo FM, Renzullo A, Accardo G, Esposito D, Barbato F, Colantuoni V, Circelli L, Conzo G. G Chir; 2012 Sep; 33(11-12):370-3. PubMed ID: 23140918 [Abstract] [Full Text] [Related]
25. The RET proto-oncogene and cancer. Donis-Keller H. J Intern Med; 1995 Oct; 238(4):319-25. PubMed ID: 7595167 [Abstract] [Full Text] [Related]
26. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2). Jimenez C, Gagel RF. Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S150-7. PubMed ID: 15135800 [Abstract] [Full Text] [Related]
27. RET gene and its implications for cancer. Goodfellow PJ, Wells SA. J Natl Cancer Inst; 1995 Oct 18; 87(20):1515-23. PubMed ID: 7563185 [Abstract] [Full Text] [Related]
28. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. Skinner MA, DeBenedetti MK, Moley JF, Norton JA, Wells SA. J Pediatr Surg; 1996 Jan 18; 31(1):177-81; discussion 181-2. PubMed ID: 8632274 [Abstract] [Full Text] [Related]
29. New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a. Gosnell JE, Sywak MS, Sidhu SB, Gough IR, Learoyd DL, Robinson BG, Delbridge LW. ANZ J Surg; 2006 Jul 18; 76(7):586-90. PubMed ID: 16813623 [Abstract] [Full Text] [Related]
31. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan. Iihara M, Yamashita T, Okamoto T, Kanbe M, Yamazaki K, Egawa S, Yamaguchi K, Obara T. Jpn J Clin Oncol; 1997 Jun 18; 27(3):128-34. PubMed ID: 9255265 [Abstract] [Full Text] [Related]
32. RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma. Jhiang SM, Fithian L, Weghorst CM, Clark OH, Falko JM, O'Dorisio TM, Mazzaferri EL. Thyroid; 1996 Apr 18; 6(2):115-21. PubMed ID: 8733882 [Abstract] [Full Text] [Related]
33. [The molecular genetics of multiple endocrine neoplasia type 2A and 2B]. Yoshimoto K. Nihon Rinsho; 1994 Apr 18; 52(4):1081-6. PubMed ID: 7910861 [Abstract] [Full Text] [Related]
36. [Multiple endocrine neoplasia type 2 in Japan: large-scale analysis of data from the MEN consortium of Japan]. Uchino S. Nihon Geka Gakkai Zasshi; 2012 Jul 18; 113(4):362-7. PubMed ID: 22928441 [Abstract] [Full Text] [Related]